Antigens in chronic lymphocytic leukemia--implications for cell origin and leukemogenesis.

[1]  David Kipling,et al.  High-throughput immunoglobulin repertoire analysis distinguishes between human IgM memory and switched memory B-cell populations. , 2010, Blood.

[2]  A. Burch,et al.  Accumulation of oxidized proteins in Herpesvirus infected cells. , 2010, Free radical biology & medicine.

[3]  P. Subbaiah,et al.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology. , 2010, Antioxidants & redox signaling.

[4]  K. Stamatopoulos,et al.  Intraclonal diversification of immunoglobulin light chains in a subset of chronic lymphocytic leukemia alludes to antigen-driven clonal evolution , 2010, Leukemia.

[5]  N. Chiorazzi,et al.  Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin. , 2010, Blood.

[6]  Yoshihiro Baba,et al.  B cell signaling and fate decision. , 2010, Annual review of immunology.

[7]  R. Spíšek,et al.  Toll‐like receptors on B‐CLL cells: expression and functional consequences of their stimulation , 2010, International journal of cancer.

[8]  Christopher A. J. Roman,et al.  The unique and immunoglobulin-like regions of surrogate light chain component lambda5 differentially interrogate immunoglobulin heavy-chain structure. , 2010, Molecular immunology.

[9]  D. Vereide,et al.  Proof for EBV's sustaining role in Burkitt's lymphomas. , 2009, Seminars in cancer biology.

[10]  Ralf Küppers,et al.  Molecular footprints of a germinal center derivation of human IgM+(IgD+)CD27+ B cells and the dynamics of memory B cell generation , 2009, The Journal of experimental medicine.

[11]  K. Stamatopoulos,et al.  The normal IGHV1-69-derived B-cell repertoire contains stereotypic patterns characteristic of unmutated CLL. , 2009, Blood.

[12]  K. Stamatopoulos,et al.  Extensive intraclonal diversification in a subgroup of chronic lymphocytic leukemia patients with stereotyped IGHV4-34 receptors: implications for ongoing interactions with antigen. , 2009, Blood.

[13]  S. Pillai,et al.  The follicular versus marginal zone B lymphocyte cell fate decision , 2009, Nature Reviews Immunology.

[14]  E. Engels,et al.  Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia , 2009, British journal of haematology.

[15]  T. Veenstra,et al.  Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin , 2009, Nature Cell Biology.

[16]  T. Tsubata,et al.  The Development and Function of Regulatory B Cells Expressing IL-10 (B10 Cells) Requires Antigen Receptor Diversity and TLR Signals1 , 2009, The Journal of Immunology.

[17]  F. Bäckhed,et al.  Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans. , 2009, The Journal of clinical investigation.

[18]  C. Copie-Bergman,et al.  Infectious agents and lymphoma development: molecular and clinical aspects , 2009, Journal of internal medicine.

[19]  J. Weill,et al.  Human marginal zone B cells. , 2009, Annual review of immunology.

[20]  J. Yélamos,et al.  The CD5 ectodomain interacts with conserved fungal cell wall components and protects from zymosan-induced septic shock-like syndrome , 2009, Proceedings of the National Academy of Sciences.

[21]  L. Lenz.  CD5 sweetens lymphocyte responses , 2009, Proceedings of the National Academy of Sciences.

[22]  G. Marti,et al.  Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice. , 2009, Journal of autoimmunity.

[23]  A. Dalloul.  CD5: a safeguard against autoimmunity and a shield for cancer cells. , 2009, Autoimmunity reviews.

[24]  K. Stamatopoulos,et al.  Molecular evidence for EBV and CMV persistence in a subset of patients with chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors , 2009, Leukemia.

[25]  H. Wardemann,et al.  Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells. , 2008, Immunity.

[26]  Xiao-Jie Yan,et al.  From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 21, 2013. For personal use only. , 2005 .

[27]  N. Rawal,et al.  Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor , 2008, The Journal of Immunology.

[28]  K. Stamatopoulos,et al.  Evidence for the significant role of immunoglobulin light chains in antigen recognition and selection in chronic lymphocytic leukemia. , 2008, Blood.

[29]  E. Meffre,et al.  Chronic Lymphocytic Leukemia Cells Recognize Conserved Epitopes Associated with Apoptosis and Oxidation , 2008, Molecular medicine.

[30]  H. Jäck,et al.  A Unique Role for the λ5 Nonimmunoglobulin Tail in Early B Lymphocyte Development1 , 2008, The Journal of Immunology.

[31]  T. Hamblin,et al.  The immunodeficiency of chronic lymphocytic leukaemia. , 2008, British medical bulletin.

[32]  V. Boussiotis,et al.  Constitutive activation of distinct BCR-signaling pathways in a subset of CLL patients: a molecular signature of anergy. , 2008, Blood.

[33]  J. Witztum,et al.  Oxidation‐specific epitopes are important targets of innate immunity , 2008, Journal of internal medicine.

[34]  R. Rosenquist,et al.  A new perspective: molecular motifs on oxidized LDL, apoptotic cells, and bacteria are targets for chronic lymphocytic leukemia antibodies. , 2008, Blood.

[35]  A. Plebani,et al.  CpG Drives Human Transitional B Cells to Terminal Differentiation and Production of Natural Antibodies , 2008, The Journal of Immunology.

[36]  S. Shinton,et al.  Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. , 2007, Journal of autoimmunity.

[37]  Nikolaos Laoutaris,et al.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis. , 2007, Blood.

[38]  N. Chiorazzi,et al.  CD5+ B cells with the features of subepithelial B cells found in human tonsils , 2007, European journal of immunology.

[39]  J. Yélamos,et al.  CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock , 2007, Proceedings of the National Academy of Sciences.

[40]  G. Klein,et al.  Clonality and methylation status of the epstein‐barr virus (EBV) genomes in IN V7W‐infected EBV‐carrying chronic lymphocytic leukemia (CLL) cell lines , 2007, International journal of cancer.

[41]  Keith Ireton,et al.  Entry of the bacterial pathogen Listeria monocytogenes into mammalian cells , 2007, Cellular microbiology.

[42]  E. Montecino-Rodriguez,et al.  Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential , 2007, Nature Reviews Immunology.

[43]  N. Caporaso,et al.  Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. , 2007, Blood.

[44]  N. Rawal,et al.  Vimentin Expressed on Mycobacterium tuberculosis-Infected Human Monocytes Is Involved in Binding to the NKp46 Receptor1 , 2006, The Journal of Immunology.

[45]  Nikolaos Laoutaris,et al.  Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.

[46]  Lisa L. Smith,et al.  Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia. , 2006, Blood.

[47]  Ralph Weissleder,et al.  Identification of the target self-antigens in reperfusion injury , 2006, The Journal of experimental medicine.

[48]  E. Montecino-Rodriguez,et al.  Identification of a B-1 B cell–specified progenitor , 2006, Nature Immunology.

[49]  H. Döhner,et al.  Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status. , 2005, Blood.

[50]  J. Weill,et al.  Splenic marginal zone B cells in humans: Where do they mutate their Ig receptor? , 2005, European journal of immunology.

[51]  Richard Rosenquist,et al.  Distinctive gene expression pattern in VH3-21 utilizing B-cell chronic lymphocytic leukemia. , 2005, Blood.

[52]  J. Witztum,et al.  Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200 , 2005, Journal of Lipid Research.

[53]  E. Meffre,et al.  Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity. , 2005, The Journal of clinical investigation.

[54]  P. Lipsky,et al.  Identification and characterization of circulating human transitional B cells. , 2005, Blood.

[55]  H. Mannherz,et al.  Activated cofilin colocalises with Arp2/3 complex in apoptotic blebs during programmed cell death. , 2005, European journal of cell biology.

[56]  Nikolaos Laoutaris,et al.  Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.

[57]  Masahiko Kato,et al.  Cleavage of nonmuscle myosin heavy chain-A during apoptosis in human Jurkat T cells. , 2005, Journal of biochemistry.

[58]  J. Kearney.  Innate-like B cells , 2005, Springer Seminars in Immunopathology.

[59]  L. Herzenberg,et al.  Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion , 2005, Springer Seminars in Immunopathology.

[60]  Jérôme Lane,et al.  IMGT®, the international ImMunoGeneTics information system® , 2004, Nucleic Acids Res..

[61]  J. Witztum,et al.  Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory , 2004, The Journal of experimental medicine.

[62]  L. Staudt,et al.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. , 2004, Blood.

[63]  C. Walsh,et al.  The many faces of filamin: A versatile molecular scaffold for cell motility and signalling , 2004, Nature Cell Biology.

[64]  Göran Roos,et al.  Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia. , 2004, Blood.

[65]  J. Gribben,et al.  Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. , 2004, Blood.

[66]  Steven L. Allen,et al.  Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia , 2004, The Journal of experimental medicine.

[67]  F. Stevenson,et al.  Chronic lymphocytic leukemia: revelations from the B-cell receptor. , 2004, Blood.

[68]  M. Boiocchi,et al.  Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. , 2004, Journal of the National Cancer Institute.

[69]  Anna Tramontano,et al.  Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia. , 2004, The Journal of clinical investigation.

[70]  A. Pettitt,et al.  High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment. , 2003, Blood.

[71]  G. Juliusson,et al.  Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope. , 2003, Blood.

[72]  J. Witztum,et al.  Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL , 2003, Nature Medicine.

[73]  A. Trautmann,et al.  CD5 Inhibits Signaling at the Immunological Synapse Without Impairing Its Formation 1 , 2003, The Journal of Immunology.

[74]  J. Orchard,et al.  Features of the overexpressed V1-69 genes in the unmutated subset of chronic lymphocytic leukemia are distinct from those in the healthy elderly repertoire. , 2003, Blood.

[75]  T. Möröy,et al.  Expression of ribosomal and translation-associated genes is correlated with a favorable clinical course in chronic lymphocytic leukemia. , 2003, Blood.

[76]  G. Bismuth,et al.  Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production. , 2002, Blood.

[77]  Xiao-Jie Yan,et al.  B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. , 2002, Blood.

[78]  P. Ghezzi,et al.  Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Göran Roos,et al.  Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.

[80]  D. Alarcón-Segovia,et al.  Characterization of anti-phosphatidylcholine polyreactive natural autoantibodies from normal human subjects. , 2002, Journal of autoimmunity.

[81]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[82]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[83]  A. Cappione,et al.  Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance. , 2001, The Journal of clinical investigation.

[84]  F. Deist,et al.  CD40-CD40L independent Ig gene hypermutation suggests a second B cell diversification pathway in humans. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[85]  P. Batstone,et al.  Primary Cutaneous B-Cell Lymphoma and Borrelia burgdorferi Infection in Patients From the Highlands of Scotland , 2000, The American journal of surgical pathology.

[86]  G. Silverman,et al.  Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. , 2000, The Journal of clinical investigation.

[87]  T. Behrens,et al.  Cd5 Maintains Tolerance in Anergic B Cells , 2000, The Journal of experimental medicine.

[88]  K. Rajewsky,et al.  Cellular origin of human B-cell lymphomas. , 1999, The New England journal of medicine.

[89]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[90]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[91]  K. Richards,et al.  VH4-34 encoded antibodies in systemic lupus erythematosus: a specific diagnostic marker that correlates with clinical disease characteristics. , 1999, The Journal of rheumatology.

[92]  P. Youinou,et al.  CD5 expression in human B-cell populations. , 1999, Immunology today.

[93]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[94]  R. Brezinschek,et al.  Pairing of variable heavy and variable kappa chains in individual naive and memory B cells. , 1998, Journal of immunology.

[95]  M. Fischer,et al.  Molecular single-cell analysis reveals that CD5-positive peripheral blood B cells in healthy humans are characterized by rearranged Vkappa genes lacking somatic mutation. , 1997, The Journal of clinical investigation.

[96]  R. Brezinschek,et al.  Analysis of the human VH gene repertoire. Differential effects of selection and somatic hypermutation on human peripheral CD5(+)/IgM+ and CD5(-)/IgM+ B cells. , 1997, The Journal of clinical investigation.

[97]  H. Mellstedt,et al.  CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM. , 1997, Blood.

[98]  L. Rassenti,et al.  Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. , 1997, Journal of immunology.

[99]  H. Wortis,et al.  B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[100]  T. Kipps,et al.  Structure-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. , 1994, Journal of immunology.

[101]  G. Dighiero,et al.  The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoire. , 1994, Immunology today.

[102]  A. Siegbahn,et al.  Epstein-Barr virus (EBV) can immortalize B-cll cells activated by cytokines. , 1994, Leukemia.

[103]  T. Logtenberg,et al.  Peripheral human CD5+ and CD5- B cells may express somatically mutated VH5- and VH6-encoded IgM receptors. , 1993, Journal of immunology.

[104]  T. C. Diss,et al.  Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori , 1993, The Lancet.

[105]  T. Logtenberg,et al.  The majority of human tonsillar CD5+ B cells express somatically mutated Vχ4 genes , 1993 .

[106]  P. Isaacson,et al.  Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma , 1991, The Lancet.

[107]  H. Velde,et al.  The B-cell surface protein CD72/Lyb-2 is the ligand for CDS , 1991, Nature.

[108]  J. Binet,et al.  Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies. , 1990, Blood.

[109]  N. Chiorazzi,et al.  Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia , 1989, The Journal of experimental medicine.

[110]  P. Lydyard,et al.  Chronic lymphocytic leukemic (CLL) cells secrete multispecific autoantibodies. , 1988, Journal of autoimmunity.

[111]  G. Klein,et al.  Direct outgrowth of in vivo epstein‐barr virus (EBV)‐infected chronic lymphocytic leukemia (CLL) cells into permanent lines , 1988, International journal of cancer.

[112]  G. Klein,et al.  Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. , 1983, Journal of immunology.

[113]  K. Takada,et al.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus III , 1981, Medical Microbiology and Immunology.

[114]  Leroy Hood,et al.  IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts , 1981, Nature.

[115]  G. Klein,et al.  Establishment of a lymphoid cell line from leukemic cells of a patient with chronic lymphocytic leukemia , 1980, International journal of cancer.

[116]  G. Klein,et al.  Chromosome analyses of lymphoid cell lines derived from patients with chronic lymphocytic leukemia , 1980, International journal of cancer.

[117]  NH Sigal,et al.  Expression of phosphorylcholine-specific B cells during murine development , 1977, The Journal of experimental medicine.

[118]  G. Klein,et al.  EB virus-induced B lymphocyte cell lines producing specific antibody , 1977, Nature.

[119]  G. Klein,et al.  Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro , 1977, Nature.

[120]  Fritz Melchers,et al.  Checkpoints in lymphocyte development and autoimmune disease , 2010, Nature Immunology.

[121]  K. Stamatopoulos,et al.  A different ontogenesis for chronic lymphocytic leukemia cases carrying stereotyped antigen receptors: molecular and computational evidence , 2010, Leukemia.

[122]  S. Pillai,et al.  Marginal zone B cells. , 2005, Annual review of immunology.

[123]  D. Markovitz,et al.  Vimentin is secreted by activated macrophages , 2003, Nature Cell Biology.

[124]  R. Berland,et al.  Origins and functions of B-1 cells with notes on the role of CD5. , 2002, Annual review of immunology.

[125]  C. Raman.  CD5, an important regulator of lymphocyte selection and immune tolerance , 2002, Immunologic research.

[126]  S. Rutella,et al.  Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. , 1999, Haematologica.

[127]  S. Avrameas,et al.  Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. , 1991, Immunology today.

[128]  F. Ross,et al.  Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement. , 1990, Leukemia research.

[129]  K. Takada,et al.  Analysis of the transformation of human lymphocytes by Epstein-Barr virus. II. Abortive response of leukemic cells to the transforming virus. , 1980, Intervirology.